Legal Insurrection by Leslie Eastman 9/18/2021
DeSantis evaluating Eli Lilly, GlaxoSmithKline treatment options.One long-term benefit of President Donald Trump’s term in office is that Americans became accustomed to seeing state governors outright rejecting presidential proposals very robustly and very publicly.
Turnabout is fair play, and Biden is now enjoying the fruits of the tree the Democrats planted and nurtured for four years.
I recently noted that the Biden Administration was planning to take over nationwide distribution of monoclonal antibody treatments. Ostensibly, officials say, it is in the name of equity, as 70% of those treatments have gone to red states.
Furthermore, Governor Ron DeSantis has had a great deal of success opening up clinics across Florida to help promote early treatment.
It appears Team Biden did not count on DeSantis’ tenacity or capitalism. The feds simply bought up all the Regeneron.
It turns out there are other monoclonal antibody treatments, and DeSantis is pursing those products.
More:
https://legalinsurrection.com/2021/09/florida-gov-ron-desantis-seeks-to-bypass-biden-hhs-buy-monoclonals-directly-from-drug-makers/